F
Fredrik Åberg
Researcher at University of Helsinki
Publications - 30
Citations - 744
Fredrik Åberg is an academic researcher from University of Helsinki. The author has contributed to research in topics: Liver disease & Population. The author has an hindex of 9, co-authored 30 publications receiving 460 citations. Previous affiliations of Fredrik Åberg include Helsinki University Central Hospital & Sahlgrenska University Hospital.
Papers
More filters
Journal ArticleDOI
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.
TL;DR: Multiple components of the metabolic syndrome independently affected the risk for severe liver disease, and alcohol was significant even when average alcohol consumption was within the limits currently defining nonalcoholic fatty liver disease.
Journal ArticleDOI
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.
Fredrik Åberg,Fredrik Åberg,Pauli Puukka,Veikko Salomaa,Satu Männistö,Annamari Lundqvist,Liisa Valsta,Markus Perola,Martti Färkkilä,Antti Jula +9 more
TL;DR: This work investigated the impact of alcohol use in fatty liver disease on incident liver, cardiovascular, and malignant disease, as well as death.
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Abstract: The metabolic syndrome and alcohol risk use are both associated with high prevalence of hepatic steatosis, but only a minority develop liver failure or liver cancer. Few general population studies have analyzed metabolic predictors of such severe liver complications. We studied which metabolic factors best predict severe liver complications, stratified by alcohol consumption. 6732 individuals without baseline liver disease who participated in the Finnish population-based Health 2000 Study (2000-2001), a nationally representative cohort. Follow-up data from national registers until 2013 were analyzed for liver-related admissions, mortality, and liver cancer. Baseline alcohol use and metabolic factors were analyzed by backward stepwise Cox regression analysis. 84 subjects experienced a severe liver event during follow-up. In the final multivariate model, factors predictive of liver events were age (HR 1.02, 95%CI 1.004-1.04), gender (women HR 0.55, 0.34-0.91), alcohol use (HR 1.002, 1.001-1.002), diabetes (HR 2.73, 1.55-4.81), LDL cholesterol (HR 0.74, 0.58-0.93), and HOMA-IR (HR 1.01, 1.004-1.02). Among alcohol risk users (average alcohol use ≥210 g/week for men, ≥140 g/week for women), diabetes (HR 6.79, 95%CI 3.18-14.5) was the only significant predictor. Among non-risk drinkers, age, alcohol use, smoking, waist circumference, low LDL cholesterol and HOMA-IR were significant independent predictors. The total cholesterol-to-LDL cholesterol-ratio and waist circumference-to-BMI-ratio emerged as additional independent predictors.
Conclusion: Multiple components of the metabolic syndrome independently affected the risk for severe liver disease. Alcohol was significant even when average alcohol consumption was within the limits currently defining non-alcoholic fatty liver disease. This article is protected by copyright. All rights reserved.
Journal ArticleDOI
Binge drinking and the risk of liver events: A population-based cohort study.
TL;DR: It is investigated whether binge drinking increases the risk for liver disease above and beyond the risk due to average alcohol consumption.
Journal ArticleDOI
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications.
TL;DR: The aim of this review is to enlighten the critical roles that the liver plays in cholesterol metabolism, and to explain why accurate lipid profile evaluation is highly important in liver disease and after liver transplantation.